iShares MSCI Japan ETF vs Herbalife Nutrition Ltd — how do they compare? iShares MSCI Japan ETF trades at $97.86 (market cap $23.87B), while Herbalife Nutrition Ltd trades at $13.03 (market cap $1.34B). The key difference: iShares MSCI Japan ETF is far larger — about 17.8× Herbalife Nutrition Ltd's market cap, and iShares MSCI Japan ETF is trading nearer its 52-week high, Herbalife Nutrition Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Japan ETF for 56 Days and Herbalife Nutrition Ltd for 43 Days on average.
| EWJ | HLF | |
|---|---|---|
Market Cap | $23.87B | $1.34B |
Volume | 5,412,820 | 1,589,457 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $99.32 | $19.96 |
52-Week Low | $78.36 | $7.75 |
Typical Hold Time | 56 Days | 43 Days |
Enterprise Value | — | $3.18B |
Signals from Pluang's Aura AI — not financial advice
EWJ, the iShares MSCI Japan ETF, trades at $97.86, down 0.47% today amid mixed technical signals. The overall technical picture is neutral with bullish moving averages but neutral oscillators, suggesting consolidation near key support at $97. Recent news highlights Japan's monetary policy shifts and regional market volatility, with the Bank of Japan's rate hike cycle creating both opportunities and challenges for Japanese equities.
The outlook for EWJ remains balanced with potential upside from Japan's economic reforms and AI sector growth, but risks include yen volatility and rising global bond yields. Investor sentiment is cautiously optimistic as international ETFs outperform US markets, though Japanese fiscal stimulus concerns and currency pressures warrant close monitoring for volatility spikes.
Herbalife (HLF) trades at $13.03, up 3.0% with a bullish technical signal. The stock shows attractive valuation metrics with P/E of 8.22 and P/S of 0.26, while maintaining strong gross margins of 77.7%. Recent Q1 2026 earnings beat expectations, though Q2 2026 missed. The company announced a $250 million share repurchase program and CEO transition, with management reaffirming 2026 guidance. Cash flow trends show improvement with projected positive net cash flow of $50 million for 2026.
HLF presents a value opportunity with discounted valuation and improving debt profile, though execution risks remain. Analyst consensus targets $19.00 (53.8% upside) with 14 buy ratings. Key risks include mixed earnings performance, high debt levels despite recent reduction, and leadership transition. The stock offers potential for re-rating if management delivers on margin expansion and growth targets outlined in recent investor presentations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
EWJ tracks the MSCI Japan Index, providing broad exposure to over 180 large and mid-cap companies in Japan. It is the most established and liquid vehicle for accessing the Japanese equity market, featuring a diversified portfolio across industrials, consumer discretionary, and financial sectors.
Read more on EWJ →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →